ID   BCR_RAT                 Reviewed;        1270 AA.
AC   F1LXF1;
DT   03-JUL-2019, integrated into UniProtKB/Swiss-Prot.
DT   23-FEB-2022, sequence version 4.
DT   02-OCT-2024, entry version 104.
DE   RecName: Full=Breakpoint cluster region protein {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:P11274};
GN   Name=Bcr {ECO:0000312|RGD:1307993};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   INTERACTION WITH DLG4, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20962234; DOI=10.1523/jneurosci.1711-10.2010;
RA   Oh D., Han S., Seo J., Lee J.R., Choi J., Groffen J., Kim K., Cho Y.S.,
RA   Choi H.S., Shin H., Woo J., Won H., Park S.K., Kim S.Y., Jo J.,
RA   Whitcomb D.J., Cho K., Kim H., Bae Y.C., Heisterkamp N., Choi S.Y., Kim E.;
RT   "Regulation of synaptic Rac1 activity, long-term potentiation maintenance,
RT   and learning and memory by BCR and ABR Rac GTPase-activating proteins.";
RL   J. Neurosci. 30:14134-14144(2010).
RN   [3] {ECO:0007744|PubMed:22673903}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Protein with a unique structure having two opposing
CC       regulatory activities toward small GTP-binding proteins. The C-terminus
CC       is a GTPase-activating protein (GAP) domain which stimulates GTP
CC       hydrolysis by RAC1, RAC2 and CDC42. Accelerates the intrinsic rate of
CC       GTP hydrolysis of RAC1 or CDC42, leading to down-regulation of the
CC       active GTP-bound form. The central Dbl homology (DH) domain functions
CC       as guanine nucleotide exchange factor (GEF) that modulates the GTPases
CC       CDC42, RHOA and RAC1. Promotes the conversion of CDC42, RHOA and RAC1
CC       from the GDP-bound to the GTP-bound form. The amino terminus contains
CC       an intrinsic kinase activity (By similarity). Functions as an important
CC       negative regulator of neuronal RAC1 activity (By similarity). Regulates
CC       macrophage functions such as CSF1-directed motility and phagocytosis
CC       through the modulation of RAC1 activity. Plays a major role as a RHOA
CC       GEF in keratinocytes being involved in focal adhesion formation and
CC       keratinocyte differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:P11274, ECO:0000250|UniProtKB:Q6PAJ1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:P11274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:P11274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000305};
CC   -!- SUBUNIT: Homotetramer. Interacts with PDZK1 (By similarity). May
CC       interact with CCPG1 (By similarity). Interacts with HCK, FES/FPS, ABL1,
CC       PIK3R1 and GRB2 (By similarity). Interacts with SH2D5 (By similarity).
CC       Interacts with DLG4 (PubMed:20962234). {ECO:0000250|UniProtKB:P11274,
CC       ECO:0000250|UniProtKB:Q6PAJ1, ECO:0000269|PubMed:20962234}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic density
CC       {ECO:0000250|UniProtKB:Q6PAJ1}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:Q6PAJ1}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q6PAJ1}. Synapse {ECO:0000269|PubMed:20962234}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, including the cortex,
CC       hippocampus, cerebellum, and brainstem, as well as the spinal cord (at
CC       protein level). {ECO:0000269|PubMed:20962234}.
CC   -!- DEVELOPMENTAL STAGE: Expression is initially high at a late embryonic
CC       (18 dpc) stage and maintained at slightly decreased levels throughout
CC       postnatal brain development. {ECO:0000269|PubMed:20962234}.
CC   -!- DOMAIN: The region involved in binding to ABL1 SH2-domain is rich in
CC       serine residues and needs to be Ser/Thr phosphorylated prior to SH2
CC       binding. This region is essential for the activation of the ABL1
CC       tyrosine kinase and transforming potential of the chimeric BCR-ABL
CC       oncogene. {ECO:0000250|UniProtKB:P11274}.
CC   -!- DOMAIN: The DH domain is involved in interaction with CCPG1.
CC       {ECO:0000250|UniProtKB:Q6PAJ1}.
CC   -!- DOMAIN: The amino terminus contains an intrinsic kinase activity. The
CC       central Dbl homology (DH) domain functions as a guanine nucleotide
CC       exchange factor (GEF) that modulates the GTPases CDC42, RHOA and RAC1.
CC       Promotes the conversion of CDC42, RHOA and RAC1 from the GDP-bound to
CC       the GTP-bound form. The C-terminus is a Rho-GAP domain which stimulates
CC       GTP hydrolysis by RAC1, RAC2 and CDC42. The protein has a unique
CC       structure having two opposing regulatory activities toward small GTP-
CC       binding proteins. {ECO:0000250|UniProtKB:P11274}.
CC   -!- PTM: Autophosphorylated. Phosphorylated by FES/FPS on tyrosine
CC       residues, leading to down-regulation of the BCR kinase activity.
CC       Phosphorylation by HCK is important for interaction with GRB2.
CC       {ECO:0000250|UniProtKB:P11274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07044649; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07044650; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; F1LXF1; -.
DR   SMR; F1LXF1; -.
DR   STRING; 10116.ENSRNOP00000001766; -.
DR   PhosphoSitePlus; F1LXF1; -.
DR   jPOST; F1LXF1; -.
DR   PaxDb; 10116-ENSRNOP00000001766; -.
DR   PeptideAtlas; F1LXF1; -.
DR   Ensembl; ENSRNOT00000001766.8; ENSRNOP00000001766.7; ENSRNOG00000001304.8.
DR   Ensembl; ENSRNOT00055037757; ENSRNOP00055030800; ENSRNOG00055021982.
DR   Ensembl; ENSRNOT00060045492; ENSRNOP00060037769; ENSRNOG00060026163.
DR   Ensembl; ENSRNOT00065040068; ENSRNOP00065032573; ENSRNOG00065023404.
DR   AGR; RGD:1307993; -.
DR   RGD; 1307993; Bcr.
DR   VEuPathDB; HostDB:ENSRNOG00000001304; -.
DR   eggNOG; KOG4269; Eukaryota.
DR   GeneTree; ENSGT00940000153491; -.
DR   HOGENOM; CLU_004164_0_0_1; -.
DR   InParanoid; F1LXF1; -.
DR   OMA; IKVKISH; -.
DR   TreeFam; TF105082; -.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013026; RHOB GTPase cycle.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013404; RAC2 GTPase cycle.
DR   PRO; PR:F1LXF1; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000001304; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:RGD.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0060216; P:definitive hemopoiesis; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0048041; P:focal adhesion assembly; ISO:RGD.
DR   GO; GO:0048872; P:homeostasis of number of cells; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0065002; P:intracellular protein transmembrane transport; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:1905517; P:macrophage migration; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISS:UniProtKB.
DR   GO; GO:0060313; P:negative regulation of blood vessel remodeling; ISO:RGD.
DR   GO; GO:0002692; P:negative regulation of cellular extravasation; ISO:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:1905522; P:negative regulation of macrophage migration; ISO:RGD.
DR   GO; GO:0043314; P:negative regulation of neutrophil degranulation; ISO:RGD.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0060268; P:negative regulation of respiratory burst; ISO:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0043312; P:neutrophil degranulation; ISO:RGD.
DR   GO; GO:0006909; P:phagocytosis; ISO:RGD.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IDA:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISO:RGD.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0019222; P:regulation of metabolic process; ISO:RGD.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; ISO:RGD.
DR   GO; GO:0043114; P:regulation of vascular permeability; ISO:RGD.
DR   GO; GO:0003014; P:renal system process; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; ISO:RGD.
DR   CDD; cd08686; C2_ABR; 1.
DR   CDD; cd04387; RhoGAP_Bcr; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 4.10.280.30; Bcr-Abl oncoprotein oligomerisation domain; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   InterPro; IPR037769; Abr/Bcr.
DR   InterPro; IPR015123; Bcr-Abl_oncoprot_oligo.
DR   InterPro; IPR036481; Bcr-Abl_oncoprot_oligo_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   PANTHER; PTHR23182:SF3; BREAKPOINT CLUSTER REGION PROTEIN; 1.
DR   PANTHER; PTHR23182; BREAKPOINT CLUSTER REGION PROTEIN BCR; 1.
DR   Pfam; PF09036; Bcr-Abl_Oligo; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF19057; PH_19; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF69036; Bcr-Abl oncoprotein oligomerization domain; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell projection; Coiled coil; GTPase activation;
KW   Guanine-nucleotide releasing factor; Kinase; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Synapse; Transferase.
FT   CHAIN           1..1270
FT                   /note="Breakpoint cluster region protein"
FT                   /id="PRO_0000447439"
FT   DOMAIN          497..690
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          707..865
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          892..1019
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1053..1247
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   REGION          67..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          201..249
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          295..396
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          412..484
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          28..55
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        201..223
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..396
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        416..430
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        458..472
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         247
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         387
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         465
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         473
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         487
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         553
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         640
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         643
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         692
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
FT   MOD_RES         1263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11274"
SQ   SEQUENCE   1270 AA;  143034 MW;  EFDB458FC779D13C CRC64;
     MVDSVGFAEA WRAQFPDSEP PRMELRSVGD IEQELERCKA SIRRLEQEVN QERFRMIYLQ
     TLLAKEKKSY DRQRWGFRRA AQPPDGAAEP RASAPRLPPA PADGADPAPV EESEARPDGE
     GSPSKGRPAT ARRPAAAAPA DRDDRGPPTS VAALRSNFEK IRKGPAQPGS ADAEKPFYVN
     VEFHHERGLV KVNDKEVSDR ISSLGSQAMQ MERKKSQQSA GQGLGEAPRP HYRGRSSESS
     CGLDGDYEDA ELNPRFLKDN LINANGGNRP PWPPLEYQPY QSIYVGGMMV EGEGKSPLLR
     SQSTSEQEKR LTWPRRSYSP RSFEDSGGGY TPDCSSNENL TSSEEDFSSG QSSRVSPSPT
     TYRMFRDKSR SPSQNSQQSF DSSSPPTPQC QKRHRQCQVV VSEATIVGVR KTGQIWPSDG
     DSTFQGEADS SFGTPPGYGC AADQAEEQRR HQDGLPYIDD SPSSSPHLSS KGRGSPASGA
     LEPTKASELD LEKGLEMRKW VLSGILASEE TYLSHLEALL LPMKPLKAAA TTSQPVLTSQ
     QIETIFFKVP ELYEIHKEFY DGLFPRVQQW SHQQRVGDLF QKLASQLGVY RAFVDNYGVA
     METAEKCCQA NAQFAEISEN LRARSNKDVK DSTTKNSLET LLYKPVDRVT RSTLVLHDLL
     KHTPSSHPDH SLLQDALRIS QNFLSSINEE ITPRRQSMTV KKGEHRQLLK DSFMVELVEG
     ARKLRHIFLF TDLLLCTKLK KQSGGKTQQY DCKWYIPLTD LSFQMVDELE ALPNIPLVPD
     EELDALKIKI SQIKSDIQRE KRANKGSKVM ERLRKKLSEQ ESLLLLMSPS MAFRVHSRNG
     KSYTFLISSD YERAEWRESI REQQKKCFKS FSLTSVELQM LTNSCVKLQT VHHIPLTINK
     EDDESPGLYG FLHAIVHSAT GFKQSSNLYC TLEVDSFGYF VNKAKTRVYR DTTEPNWNEE
     FEIELEGSQT LRILCYEKCY NKMKMAKEDG ESADKLMGKG QVQLDPQTLQ DRDWQRTVID
     MNGIEVKLSV KFTSREFSLK RMPSRKQTGV FGVKIAVVTK RERSKVPYIV RQCVEEIERR
     GMEEVGIYRV SGVATDIQAL KAAFDVNNKD VSVMMSEMDV NAIAGTLKLY FRELPEPLFT
     DEFYPNFAEG IALSDPVAKE SCMLNLLLSL PEANLLTFLF LLDHLKRVAE KETVNKMSLH
     NLATVFGPTL LRPSEKESKL PANPSQPITM TDSWSLEVMS QVQVLLYFLQ LEAIPAPDSK
     RQSILFSTEV
//
